PlainRecalls
FDA Drug Moderate Class II Terminated

Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.

Reported: November 25, 2020 Initiated: November 1, 2020 #D-0077-2021

Product Description

Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Details

Units Affected
99 bottles (9990 Extended Release Tablets)
Distribution
Distributed to two physician's offices located in FL.
Location
Anaheim, CA

Frequently Asked Questions

What product was recalled?
Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.. Recalled by Preferred Pharmaceuticals, Inc.. Units affected: 99 bottles (9990 Extended Release Tablets).
Why was this product recalled?
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 25, 2020. Severity: Moderate. Recall number: D-0077-2021.